Palantir Technologies Inc. (PLTR) spent most of 2025 taking heat for its valuation. Analysts argued about the multiple, investors questioned the price, and critics recycled the "defense-only" narrative. Meanwhile, the company was busy doing something else entirely: signing deals at a pace that would make most enterprise software companies dizzy.

In 10 months, Palantir locked down 26 partnerships across 15 different sectors. That's not a gradual diversification strategy. That's a blitz.

A Partnership Roster That Spans Nearly Everything

The scope here is worth appreciating. PwC UK, Deloitte and Accenture Federal Services brought Palantir deeper into the consulting world. Lumen Technologies Inc. (LUMN) and Lear Corp (LEA) opened doors in telecom and automotive. SOMPO, TWG Global and Société Générale expanded its footprint in insurance and financial services.

Aviation partnerships came through FTAI Aviation Ltd (FTAI) and Archer Aviation Inc. (ACHR), while mobility got a boost from EYSA. And healthcare? Palantir went from peripheral player to omnipresent, signing OneMedNet, the Joint Commission, R1 and multiple NHS-linked programmes.

The Industrial Push That Flew Under the Radar

Beyond the headline names, the industrial expansion might be the most underestimated piece of this story. Fedrigoni, Valoriza, SAUR, BlueForge and six Warp Speed manufacturing customers pulled Palantir into reindustrialization, environmental services and utilities.

Dubai Holding's Aither added sovereign-level depth. The Nuclear Company partnership and UK Armed Forces simulations via Hadean pushed the company further into energy infrastructure and defense-tech modernization.

Speed Matters More Than Volume

Enterprise AI doesn't typically move this fast into regulated industries. Banks, healthcare systems, defense contractors—they don't just adopt new software on a whim. Yet Palantir managed to crack 15 different sectors in under a year. That's not pipeline building. That's a fundamental repositioning of what the company is and who it serves.

What This Means for the Stock

Here's the tension: Palantir still trades like a valuation argument waiting to be resolved, but the deal flow reads like a multi-industry takeover already in progress. If 2025 was supposed to be the year Palantir proved it could expand beyond defense, the company didn't ease into it. It went wide, moved fast and didn't ask permission.

Heading into 2026, the real question isn't whether Palantir is expanding. It's whether the market will look up from the price-to-sales ratio long enough to notice the company that's emerging on the other side of all these deals.